Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: Implications for gross examination, cytology, and clinical follow-up

American Journal of Surgical Pathology

Volumn 26, Issue 2, 2002, Pages 171-178

  Agoff, S Nicholas ^a   Mendelin, Joel E ^a   Grieco, Verena S ^a   Garcia, Rochelle L ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

BRCA 1; Fallopian tube carcinoma; Peritoneal cytology; Prophylactic hysterectomy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CARCINOGENESIS; CARCINOMA IN SITU; CLINICAL ARTICLE; CYSTADENOCARCINOMA; EARLY CANCER; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; HYSTERECTOMY; PERITONEAL FLUID; SALPINGOOOPHORECTOMY; UTERINE TUBE CARCINOMA; UTERUS MYOMA;

ADENOCARCINOMA; ADENOFIBROMA; ADULT; AGED; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FALLOPIAN TUBE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYSTERECTOMY; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL;

EID: 0036158840     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200202000-00003     Document Type: Article

References (31)

1. Carcinoma of the fallopian tube: A clinicopathologic study of 105 cases with observations on staging and prognostic factors
2. A genetic epidemiological study of carcinoma of the fallopian tube
3. Carcinoma of the fallopian tube
4. BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum
5. Benign and borderline clear cell adenofibromas of the ovary
6. BRCA1 and BRCA2: From molecular genetics to clinical medicine
7. Extraovarian peritoneal serous papillary carcinoma: A case-control retrospective comparison to papillary adenocarcinoma of the ovary
8. Molecular biology in radiation oncology: Radiation oncology perspective of BRCA1 and BRCA2
9. The pathologic examination of prophylactic oophorectomy specimens
10. The prognostic value of peritoneal cytology in gynecologic malignant disease
11. Breast and ovarian cancer incidence in BRCA1-mutation carriers: Breast Cancer Linkage Consortium
12. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: The Breast Cancer Linkage Consortium
13. Clear cell carcinoma of the fimbria of the fallopian tube in a BRCA1 carrier undergoing prophylactic surgery
14. Primary carcinoma of the fallopian tube
15. Surgical staging of early invasive epithelial ovarian tumors
16. Evidence of a founder BRCA1 mutation in Scotland
17. Hereditary and familial ovarian cancer in southern Ontario
18. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: A case for recommending hysterectomy at surgical prophylaxis
19. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer: A report of the Gilda Radner Familial Ovarian Cancer Registry
20. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers
21. Germline BRCA2 mutation in a patient with fallopian tube carcinoma: A case report
22. Ovarian clear cell adenofibromatous tumors: Benign, of low malignant potential, and associated with invasive clear cell carcinoma
23. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations
24. BRCA2 in American families with four or more cases of breast or ovarian cancer: Recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2
25. Primary carcinoma of the fallopian tube
26. Fallopian tube cancer as a feature of BRCA1-associated syndromes
27. Intraabdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families
28. BRCA1 gene mutations in sporadic ovarian carcinomas: Detection by PCR and reverse allele-specific oligonucleotide hybridization
29. Mucosal epithelial proliferation of the fallopian tube: Prevalence, clinical associations, and optimal strategy for histopathologic assessment
30. Carcinoma of the fallopian tube
31. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations